Rojas-Martínez Augusto
Facultad de Medicina and Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León, Carlos Canseco S.N. Colonia Mitras Centro, Monterrey, C.P. 64460, Mexico,
J Community Genet. 2015 Jul;6(3):313-9. doi: 10.1007/s12687-015-0233-5. Epub 2015 May 20.
A law known as "Genomic Sovereignty Act", instituted in 2011, regulates research on the human genome in Mexico. This law establishes Government regulations for the exportation of DNA samples from Mexican nationals for population genetics studies. The Genomic Sovereignty Act protects fundamental human values, as confidentiality and non-discrimination based on personal genetic information. It also supports the development of the genome-based medical biotechnology and the bio-economy. Current laws for the protection of the genomic confidentiality, however, are inexplicit and insufficient, and the legal and technological instruments are primitive and insufficient to safeguard this bioethical principle. In addition, this law may undermine efforts of the national and international scientific communities to cooperate with big-data analysis for the development of the genome-based biomedical sciences. The argument of this article is that deficiencies in the protection of the confidentiality of genomic information and limitations in data sharing severely weaken the objectives and scope of the Genomic Sovereignty Act. In addition, the Act may compromise the national biomedical development and the international cooperation for research and development in the field of human genomics.
2011年制定的一项名为《基因组主权法》的法律对墨西哥的人类基因组研究进行规范。该法律确立了政府对墨西哥国民DNA样本出口用于群体遗传学研究的规定。《基因组主权法》保护基本的人类价值观,如基于个人基因信息的保密性和非歧视性。它还支持基于基因组的医学生物技术和生物经济的发展。然而,目前保护基因组保密性的法律不明确且不充分,法律和技术手段原始且不足以维护这一生物伦理原则。此外,该法律可能会破坏国家和国际科学界为基于基因组的生物医学科学发展进行大数据分析合作的努力。本文的论点是,基因组信息保密性保护方面的缺陷以及数据共享的限制严重削弱了《基因组主权法》的目标和范围。此外,该法案可能会损害国家生物医学发展以及人类基因组学领域的国际研发合作。